AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-136 Cr | ₹17 Cr | ₹92 Cr | ₹-81 Cr | ₹-215 Cr |
What is the latest Cash Flow from Financing Activities ratio of AARTI DRUGS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-136 Cr |
Mar2023 | ₹17 Cr |
Mar2022 | ₹92 Cr |
Mar2021 | ₹-81 Cr |
Mar2020 | ₹-215 Cr |
How is Cash Flow from Financing Activities of AARTI DRUGS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-136 Cr | Negative | |
Mar2023 | ₹17 Cr | -82.02 | |
Mar2022 | ₹92 Cr | Positive | |
Mar2021 | ₹-81 Cr | Negative | |
Mar2020 | ₹-215 Cr | - |
Compare Cash Flow from Financing Activities of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹3,499.1 Cr | -7.8% | -9% | -25.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,044.0 Cr | -0.2% | -1% | 9.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,537.0 Cr | -2.1% | 1.5% | 61.3% | Stock Analytics | |
CIPLA | ₹118,889.0 Cr | -0% | 2% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,075.0 Cr | -1.4% | -6.1% | -4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,832.5 Cr | -5.2% | -4.7% | 8.9% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -7.8% |
-9% |
-25.5% |
SENSEX | -2.5% |
-0.8% |
7.1% |
You may also like the below Video Courses